Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living With HIV

NCT05570812 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05570812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05570812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living With HIV
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
March 3, 2023
Completion date
January 31, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety depression, hiv, major depressive disorder